Related Experiment Video

Updated: Feb 10, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.3K

Efficacy and risks of anticoagulation for cerebral venous thrombosis

Weilin Xu1, Liansheng Gao, Tao Li

  • 1Department of Neurosurgery, Second Affiliated Hospital, School of Medicine Brain Research Institute Collaborative Innovation Center for Brain Science, Zhejiang University, Hangzhou, Zhejiang, China.

Medicine
|May 17, 2018
PubMed

Insights

Anticoagulant therapy with heparin, including low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH), is effective and safe for cerebral venous thrombosis (CVT). LMWH demonstrates superior outcomes compared to UFH, even in cases with hemorrhagic stroke.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Pharmacology

Background:

  • Cerebral venous thrombosis (CVT) is a rare yet critical condition.
  • Prompt and appropriate treatment is vital for patient survival and preventing long-term neurological damage.

Purpose of the Study:

  • To conduct a network meta-analysis evaluating the efficacy and safety of anticoagulation in CVT.
  • Specifically assess anticoagulation's role in CVT patients with concomitant hemorrhagic stroke.

Main Methods:

  • Comprehensive literature search across PubMed, Embase, Web of Science, Cochrane, and CBM databases.
  • Network meta-analysis utilizing classical frequency statistics.
  • Inclusion of 14 studies with 1135 cases.

Main Results:

  • Both LMWH and UFH showed significant effectiveness and safety compared to placebo in CVT management.
  • LMWH demonstrated advantages over UFH in overall CVT treatment.
  • For CVT patients with hemorrhagic stroke, LMWH and UFH were superior to placebo, with LMWH proving more effective than UFH.

Conclusions:

  • Heparin anticoagulation is a safe and beneficial treatment for CVT patients, including those with hemorrhagic stroke.
  • Low-molecular-weight heparin (LMWH) offers better management outcomes for CVT compared to unfractionated heparin (UFH).
Abstract

More Related Videos

Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis06:03

Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis

Published on: July 12, 2011

17.8K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.4K

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
478
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
378
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
269
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
352
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
234